We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
Cap. Flow
+$1.4B
Cap. Flow %
22.72%
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$40.9M
2
PFE icon
Pfizer
PFE
+$37.8M
3
HON icon
Honeywell
HON
+$33.2M
4
JPM icon
JPMorgan Chase
JPM
+$32.4M
5
CME icon
CME Group
CME
+$31.7M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$33.3M
2
PYPL icon
PayPal
PYPL
+$33.1M
3
AMZN icon
Amazon
AMZN
+$32.1M
4
PPG icon
PPG Industries
PPG
+$27.6M
5
ADSK icon
Autodesk
ADSK
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 14.63%
3 Healthcare 13.67%
4 Financials 11.93%
5 Industrials 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UEC icon
2151
Uranium Energy
UEC
$4.71B
$22K ﹤0.01%
+25,540
New +$24.7K
HEXO
2152
DELISTED
HEXO Corp. Common Shares
HEXO
$22K ﹤0.01%
+534
New +$19.3K
OTLK icon
2153
Outlook Therapeutics
OTLK
$264M
$21K ﹤0.01%
+810
New +$14.4K
ALBT
2154
DELISTED
Avalon GloboCare
ALBT
$20K ﹤0.01%
+71
New +$17.4K
SB icon
2155
Safe Bulkers
SB
$781M
$19K ﹤0.01%
+15,190
New +$16.6K
HTT
2156
High Templar Tech Ltd
HTT
$377M
$18K ﹤0.01%
+10,579
New +$17.5K
COCP icon
2157
Cocrystal Pharma
COCP
$12.4M
$16K ﹤0.01%
+859
New +$10.5K
CLRB icon
2158
Cellectar Biosciences
CLRB
$19.3M
$14K ﹤0.01%
+37
New +$15.5K
SCYX icon
2159
SCYNEXIS
SCYX
$37M
$14K ﹤0.01%
240
-242
-50% -$16.4K
NEOS
2160
DELISTED
Neos Therapeutics, Inc
NEOS
$14K ﹤0.01%
+20,774
New +$16.5K
VAL
2161
DELISTED
Valaris plc Class A Ordinary Share
VAL
$14K ﹤0.01%
+21,477
New +$12.2K
MBRX icon
2162
Moleculin Biotech
MBRX
$15M
$11K ﹤0.01%
+5
New +$11.9K
DOMH icon
2163
Dominari Holdings
DOMH
$59.7M
$10K ﹤0.01%
+724
New +$9.06K
LONE
2164
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$10K ﹤0.01%
+20,882
New +$13K
ALTO icon
2165
Alto Ingredients
ALTO
$360M
$9K ﹤0.01%
+12,911
New +$6.51K
CARM
2166
DELISTED
Carisma Therapeutics
CARM
$9K ﹤0.01%
+592
New +$7.98K
DMK
2167
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9K ﹤0.01%
+229
New +$7.83K
HTGM
2168
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$9K ﹤0.01%
70
-459
-87% -$40.5K
NMTR
2169
DELISTED
9 Meters Biopharma
NMTR
$8K ﹤0.01%
+703
New +$7.93K
NUWE icon
2170
Nuwellis
NUWE
$189K
0
TRAW icon
2171
Traws Pharma
TRAW
$7.43M
$6K ﹤0.01%
+28
New +$4.28K
GHSI
2172
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$6K ﹤0.01%
+46
New +$6.41K
SENS icon
2173
Senseonics Holdings Inc
SENS
$254M
$5K ﹤0.01%
588
-3,092
-84% -$31.9K
TALO.WS
2174
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$4K ﹤0.01%
19,146
NE
2175
DELISTED
Noble Corporation
NE
$4K ﹤0.01%
+11,105
New +$2.85K

Similar funds

Squarepoint's Q2 2020 Portfolio in Review

As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.

  • Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
  • Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
  • Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
  • Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
  • Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
  • Squarepoint opened 906 new positions and closed 520 in Q2 2020.
  • Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.

Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.